To validate the effects of HDAC6 and USP9X inhibition in animal models, we established a GBM subcutaneous xenograft model by implanting HDAC6 and USP9X‐silenced U251 cells into immunocompromised nude mice. Here, HDAC6 is linked to glioblastoma.